Trials / Unknown
UnknownNCT03444857
CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients
Effect of Continuous Positive Airway Pressure (CPAP) for Obstructive Sleep Apnea (OSA) on Myocardial Salvage After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: A Prospective, Multicenter, Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized controlled trial to investigate the effects of CPAP treatment on myocardial salvage index and clinical outcomes at 3 months in patients with OSA and ST-Segment Elevation Myocardial Infarction (STEMI) after primary percutaneous coronary intervention (PPCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous positive airway pressure | The optimal continuous positive airway pressure (CPAP, AutoSet S9, ResMed, Sydney, Australia) settings will be determined during 1-2 nights within 7 days after pPCI. |
Timeline
- Start date
- 2018-03-26
- Primary completion
- 2019-03-24
- Completion
- 2019-06-30
- First posted
- 2018-02-23
- Last updated
- 2018-02-23
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03444857. Inclusion in this directory is not an endorsement.